These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38540131)

  • 21. Panitumumab-DOTA-
    Facca VJ; Cai Z; Gopal NEK; Reilly RM
    Mol Pharm; 2022 Oct; 19(10):3652-3663. PubMed ID: 35926098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Withania
    Maarouf RE; Azab KS; El Fatih NM; Helal H; Rashed L
    Hum Exp Toxicol; 2023; 42():9603271231180849. PubMed ID: 37294601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the phytoestrogens genistein and daidzein on BRCA2 tumor suppressor gene expression in breast cell lines.
    Vissac-Sabatier C; Bignon YJ; Bernard-Gallon DJ
    Nutr Cancer; 2003; 45(2):247-55. PubMed ID: 12881020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing Apoptosis and Necrosis Effects of Arctium Lappa Root Extract and Doxorubicin on MCF7 and MDA-MB-231 Cell Lines.
    Ghafari F; Rajabi MR; Mazoochi T; Taghizadeh M; Nikzad H; Atlasi MA; Taherian A
    Asian Pac J Cancer Prev; 2017 Mar; 18(3):795-802. PubMed ID: 28441789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells.
    Rajah TT; Du N; Drews N; Cohn R
    Pharmacology; 2009; 84(2):68-73. PubMed ID: 19556829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MELK as a potential target to control cell proliferation in triple-negative breast cancer MDA-MB-231 cells.
    Li G; Yang M; Zuo L; Wang MX
    Oncol Lett; 2018 Jun; 15(6):9934-9940. PubMed ID: 29805690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of antiproliferative effect of Chamerion angustifolium water extract and its fractions on several breast cancer cell lines.
    Maruška A; Ugenskienė R; Raulinaitytė D; Juozaitytė E; Kaškonienė V; Drevinskas T; Stelmakienė A; Akuneca I; Makaravičius T; Tiso N; Bartkuvienė V; Kornyšova O; Ragažinskienė O; Ramanauskienė K; Briedis V
    Adv Med Sci; 2017 Mar; 62(1):158-164. PubMed ID: 28282602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio.
    Pons DG; Nadal-Serrano M; Blanquer-Rossello MM; Sastre-Serra J; Oliver J; Roca P
    J Cell Biochem; 2014 May; 115(5):949-58. PubMed ID: 24375531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-specific cytotoxic effect of pyrazole derivatives on breast cancer cell lines MCF7 and MDA-MB-231.
    Lehmann TP; Kujawski J; Kruk J; Czaja K; Bernard MK; Jagodzinski PP
    J Physiol Pharmacol; 2017 Apr; 68(2):201-207. PubMed ID: 28614769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of local anesthetics on breast cancer cell viability and migration.
    Li R; Xiao C; Liu H; Huang Y; Dilger JP; Lin J
    BMC Cancer; 2018 Jun; 18(1):666. PubMed ID: 29914426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Equol as a potent radiosensitizer in estrogen receptor-positive and -negative human breast cancer cell lines.
    Taghizadeh B; Ghavami L; Nikoofar A; Goliaei B
    Breast Cancer; 2015 Jul; 22(4):382-90. PubMed ID: 24014377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ) inhibits human breast cancer cell line tumorigenicity.
    Yao PL; Morales JL; Zhu B; Kang BH; Gonzalez FJ; Peters JM
    Mol Cancer Ther; 2014 Apr; 13(4):1008-17. PubMed ID: 24464939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential regulation of the human 'leukemia inhibitory factor' (LIF) promoter in T47D and MDA-MB 231 breast cancer cells.
    Bamberger AM; Thuneke I; Schulte HM
    Breast Cancer Res Treat; 1998 Jan; 47(2):153-61. PubMed ID: 9497103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bisphenol AF stimulates transcription and secretion of C-X-C chemokine ligand 12 to promote proliferation of cultured T47D breast cancer cells.
    Li M; Han X; Gao W; Chen F; Shao B
    Toxicology; 2015 Dec; 338():30-6. PubMed ID: 26435001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tamoxifen enhances the cytotoxic effects of nelfinavir in breast cancer cells.
    Brüning A; Friese K; Burges A; Mylonas I
    Breast Cancer Res; 2010; 12(4):R45. PubMed ID: 20594311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells.
    Ma B; Guo W; Shan M; Zhang N; Ma B; Sun G
    Open Life Sci; 2020; 15(1):501-510. PubMed ID: 33817238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor].
    Lin Y; Wang SM; Huang RP
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1419-23. PubMed ID: 16029657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells.
    Chekhun SV; Lukyanova NY; Shvets YV; Burlaka AP; Buchinska LG
    Exp Oncol; 2014 Sep; 36(3):179-83. PubMed ID: 25265351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altering bioelectricity on inhibition of human breast cancer cells.
    Berzingi S; Newman M; Yu HG
    Cancer Cell Int; 2016; 16():72. PubMed ID: 27688735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer.
    Singel SM; Cornelius C; Batten K; Fasciani G; Wright WE; Lum L; Shay JW
    Clin Cancer Res; 2013 Apr; 19(8):2061-70. PubMed ID: 23479679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.